Skip to Content
  • Previous Rank
    -
  • Revenue 3 Yr Annual Growth Rate
    33%
  • Revenue 3 Yr Growth Rank
    42
  • EPS 3 Yr Annual Growth Rate
    64%
  • EPS 3 Yr Growth Rank
    31
  • Total Return 3 Yr Annual Rate
    34%
  • Total Return 3 Yr Rank
    32

Company Information

Revenue and net income for the four quarters ended on or before April 30, 2019. Total return for the period ended June 28, 2019.
Industry
Medical Products & Equipment
Sector
Health Care
Current Streak1
Years on List4
CEO
Michael Minogue
Websitehttps://www.abiomed.com
Country
U.S.
Headquarters
Danvers, Mass.
Ticker
ABMD

Revenue, Net Income

Revenue past four quarters ($M)$769
Net Income past four quarters ($M)$259
Market Value as of June 28, 2019 ($M)$11,796

Growth Rates and Ranks

Revenue 3 Yr Growth Rank42
Revenue 3 Yr Annual Growth Rate33%
EPS 3 Yr Growth Rank31
EPS 3 Yr Annual Growth Rate64%
Total Return 3 Yr Rank32
Total Return 3 Yr Annual Rate34%
Beat S&P 500 3 Yr Return (14.2%)
yes